←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, Clinical Trials
Sebastian Stintzing
MD
🏢Charite Universitatsmedizin Berlin🌐Germany
Professor of Hematology and Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sebastian Stintzing led the FIRE-3 trial demonstrating the importance of primary tumor sidedness and RAS wild-type status in selecting EGFR therapy for metastatic colorectal cancer. He has developed consensus molecular subtype classifiers linked to treatment response.
Share:
🧪Research Fields 研究领域
FIRE-3
left vs right CRC
primary tumor sidedness
molecular subtyping
consensus molecular subtypes
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sebastian Stintzing 的研究动态
Follow Sebastian Stintzing's research updates
留下邮箱，当我们发布与 Sebastian Stintzing（Charite Universitatsmedizin Berlin）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment